@enfantdegaralo: #duo avec @Doums223 🇲🇱🇫🇷 #doums223🇲🇱🇫🇷

ENFANT DE GARALO💪
ENFANT DE GARALO💪
Open In TikTok:
Region: IT
Monday 03 August 2026 20:39:23 GMT
14463
1614
78
5

Music

Download

Comments

koumbaty1
Koumbaty :
2026-08-03 21:24:02
3
223prince1
OUOLOGUEM HAMADOUN :
garalo ka diaby mon combat
2026-08-03 20:41:42
3
el.negrito8530
El negrito :
campion dem
2026-08-03 20:41:05
1
miss_traore13
Miss traoré 13 :
Cette fois ci tu à tort vraiment
2026-08-03 22:21:17
0
.traor42
Traoré :
2026-08-03 20:51:38
0
yayouss.kon1
Yayouss Koné 🇨🇮 ⚔️🇯🇲 LA4 :
😂😂😂
2026-08-03 22:44:23
1
lil.p223.com
Lil p223.com :
🤣🤣🤣
2026-08-03 22:31:32
0
paname776
Foot ball :
😂😂😂
2026-08-03 22:44:57
0
bah50640
Bah :
😂😂😂
2026-08-03 22:41:27
0
kanea57
kane :
💕💕💕
2026-08-03 22:35:37
0
damoshop2
Damo shop🇲🇱Bg🇲🇱❤️👈 :
😂😂😂😂
2026-08-03 22:46:13
0
sidy.diarra76
Sidy Diarra🇲🇱🇲🇱🇪🇸 :
🥰🥰🥰
2026-08-03 22:29:12
0
adamakonat909
AdamaKonaté🇨🇮🇲🇱✅ :
🥰🥰🥰
2026-08-03 22:15:43
0
alitraore6817
Ali Traore96982586 :
😂😂
2026-08-03 22:12:00
0
mohamedtraor194
Mohamed Traoré :
😂😂😂
2026-08-03 22:07:38
0
karaki648
🎸KA RA 🎤 :
😂😂😂
2026-08-03 22:05:54
0
usr0672336307a
Yacou 🇲🇱 :
😂😂😂
2026-08-03 20:40:55
0
To see more videos from user @enfantdegaralo, please go to the Tikwm homepage.

Other Videos

🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming
🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming

About